Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 25 of 91 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/31/14
End: 05/31/16
Due: 05/31/17
Phase: N/A
Priority: Normal
Start: 11/30/12
End: 03/31/17
Due: 03/31/18
Phase: N/A
Priority: Normal
Start: 01/03/17
End: 04/30/19
Due: 04/30/20
Phase: N/A
Priority: Normal
Start: 05/21/21
End: 09/30/23
Due: 09/30/24
Phase: N/A
Priority: Normal
Start: 09/01/20
End: 03/12/21
Due: 03/12/22
Phase: N/A
Priority: Normal
Start: 10/10/19
End: 02/10/20
Due: 02/10/21
Phase: N/A
Priority: Normal
Start: 08/31/11
End: 12/31/15
Due: 12/31/16
Phase: N/A
Priority: Normal
Start: 01/31/15
End: 12/30/16
Due: 12/30/17
Phase: N/A
Priority: Normal
Start: 06/01/21
End: 12/31/24
Due: 12/31/25
Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCC
Phase: N/A
Priority: Normal
Start: 06/30/13
End: 01/31/16
Due: 01/31/17
Phase: N/A
Priority: Normal
Start: 05/31/11
End: 03/31/16
Due: 03/31/17
Phase: N/A
Priority: Normal
Start: 01/12/21
End: 08/01/22
Due: 08/01/23
Phase: N/A
Priority: Normal
Start: 01/01/20
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 09/01/19
End: 01/29/20
Due: 01/29/21
Phase: N/A
Priority: Normal
Start: 05/01/23
End: 05/01/25
Due: 05/01/26
Phase: N/A
Priority: Normal
Start: 09/01/19
End: 08/31/23
Due: 08/31/24
Phase: N/A
Priority: Normal
Start: 09/30/12
End: 03/31/16
Due: 03/31/17
Phase: N/A
Priority: Normal
Start: 11/30/24
End: 01/31/27
Due: 01/31/28
Phase: N/A
Priority: Normal
Start: 07/22/15
End: 06/06/23
Due: 06/06/24
Phase: N/A
Priority: Normal
Start: 01/30/23
End: 08/15/23
Due: 08/15/24
Phase: N/A
Priority: Normal
Start: 04/30/10
End: 04/30/13
Due: 04/30/14
Phase: N/A
Priority: Normal
Start: 02/27/21
End: 08/01/21
Due: 08/01/22
Phase: N/A
Priority: Normal
Start: 06/01/23
End: 08/31/24
Due: 08/31/25
Phase: N/A
Priority: Normal
Start: 02/01/18
End: 09/01/20
Due: 09/01/21
Phase: N/A
Priority: Normal
Start: 05/01/16
End: 09/01/16
Due: 09/01/17